TearLab
TearLab Corporation (www.tearlab.com) develops and markets laboratory point of care technologies that enable eye care practitioners to improve standard of care by objectively testing for disease bio-markers in tears at the point-of-care. The TearLab® osmolarity test aids in the diagnosis Dry Eye Disease, is the first assay developed for the award-winning TearLab Osmolarity System.
Last updated on
About TearLab
Founded
2003Estimated Revenue
$10M-$50MEmployees
51-250Funding / Mkt. Cap
$103MCategory
Industry
Medical DevicesLocation
City
EscondidoState
CaliforniaCountry
United StatesTearLab
Find your buyer within TearLab